Posted: Mon., Sep. 24, 2007, 5:01pm PT

MSNBC locks schedule shift

Dan Abrams named official 9 p.m. host

MSNBC has shifted Dan Abrams from network executive to 9 p.m. host, making official a long-expected shuffle triggered by the firing of morning host Don Imus last April.

To fill the unexpected void in the morning after Imus was axed, MSNBC shifted former Florida congressman Joe Scarborough to the three-hour morning slot. Abrams, who had just been named general manager of the network, filled in over the summer at 9 p.m.

On Monday, NBC News made those moves permanent, with Scarborough at the helm of "Morning Joe," and Abrams host of "Live With Dan Abrams" at 9 p.m.

Abrams gives up management duties in the switch; NBC News senior veep Phil Griffin resumes day-to-day management of the network.

In October, when MSNBC's operations will be merged into NBC News headquarters at the Peacock's 30 Rock headquarters, NBC will add an executive, Sharon High-Bassalik, former veep at CBS affiliate WFOR/WBFS in Miami as managing editor for news.

At 9 p.m., Abrams gets the benefit of a lead-in from Keith Olbermann, the network's highest-rated primetime personality.

In August, Abrams was third at 9 p.m. behind Fox News' "Hannity & Colmes" and CNN's "Larry King Live."


TALKBACK:

Here is what others are saying about this article:

MSNBC morning programing is off my ... read more >




Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


Q What are the top 3 things affecting our industry today?
A. Martin - 1) The inability to take chances on new blood. 2) Aiming for the middle. 3) Self-imposed... more >


Submit this form
© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.